Even if you meet the diagnostic criteria weve discussed, you would not be indicated for a weight loss peptide if you are: Pregnant Animal studies show that the offspring of pregnant subjects exposed to GLP-1 RAs may develop skeletal abnormalities, have a low birth weight, and exhibit substandard growth.23 Although no congenital malformations have been widely identified in humans, people who are pregnant or planning to become pregnant are advised to forgo or end their GLP-1 RA treatment
Ask for the exact criteria used, gather supporting documentation with your prescriber, and submit an internal appeal or resubmission (depending on plan instructions)
Nitric-oxide (NO), VEGF/VEGFR2, and FAK-paxillin pathway activity in cell-culture models of soft-tissue repair using BPC-157
Report any significant changes to your healthcare team promptly
Trade-offs: Can cause morning grogginess, orthostatic hypotension, or REM alterations